Cotización Nanobiotix - NBTX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

2.13

Postura de Compra

2.15

Postura de Venta

6.10

Volume Operado de la Acción

18,423

4.07 Rango del Día 4.4099

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

100.394M

Precio Anterior

4.362

Precio de Apertura

4.40

Hora

2000

2.13

(formt)

Última hora de negociación

Volumen financiero

US$ 78,079

Precio Promedio Ponderado

4.2382

Volumen promedio (3 m)

Acciones en circulación

47,133,328

Rendimiento del Dividendo

Ratio Precio/Utilidad

-4.59

Beneficio por acción (BPA)

-0.84

turnover

36.21M

Beneficio neto

-39.7M

Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying ... Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its lead product candidate is NBTXR3, a preclinical research program for cancer immunotherapies. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.nanobiotix.com

Sede

Paris, Paris, Fra

Fundado

Nanobiotix SA is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NBTX. The last closing price for Nanobiotix was US$4.36. Over the last year, Nanobiotix shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Nanobiotix currently has 47,133,328 shares in issue. The market capitalisation of Nanobiotix is US$205.60 million. Nanobiotix has a price to earnings ratio (PE ratio) of -4.59.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CONLGraniteShares ETF Trust GraniteShares	US$ 43.12 (61.62%)	25.09M
ARBBARB IOT Group Ltd	US$ 0.802709 (42.20%)	227.42M
ELWSEarlyworks Co Ltd	US$ 6.00 (41.18%)	6.04M
CTKBCytek Biosciences Inc	US$ 7.40 (36.03%)	4.19M
TMCITreace Medical Concepts Inc	US$ 7.78 (35.07%)	3.15M
BNOXBionomics Ltd	US$ 0.2839 (-42.41%)	17.56M
VSTEVast Renewable Ltd	US$ 3.09 (-42.35%)	2.65M
ZCARZoomcar Holdings Inc	US$ 7.6899 (-41.74%)	1.33M
ZVSAZyVersa Therapeutics Inc	US$ 1.5242 (-39.99%)	2.07M
TNGXTango Therapeutics Inc	US$ 3.22 (-37.84%)	14.86M
ELABElevai Labs Inc	US$ 0.0173 (-19.16%)	303.44M
NVDANVIDIA Corporation	US$ 145.61 (4.07%)	232.47M
ARBBARB IOT Group Ltd	US$ 0.802709 (42.20%)	224.6M
SQQQProShares UltraPro Short QQQ	US$ 6.6503 (-8.02%)	214.38M
DJTTrump Media and Technology Group Corporation	US$ 35.955 (5.94%)	171.54M